Monday, September 21, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Major Institutions Bet Big on Cleveland-Cliffs Stock

Robert Sasse by Robert Sasse
August 26, 2025
in Stocks
0
Cleveland-Cliffs Stock
0
SHARES
413
VIEWS
Share on FacebookShare on Twitter

Despite posting a quarterly loss, Cleveland-Cliffs Inc. is attracting significant capital from heavyweight institutional investors. Major financial players are making substantial moves into the steel producer’s equity, signaling a notable vote of confidence that counters prevailing market pessimism.

A Surge in Institutional Investment

Recent regulatory filings reveal a wave of aggressive buying from institutional funds. Leading the charge, Nuveen LLC established a major new position by acquiring over 1.1 million shares, an investment valued at approximately $9.4 million. This move was far from isolated.

Wexford Capital dramatically expanded its stake by a staggering 1,212 percent. Concurrently, UBS Asset Management increased its holdings by 22.9 percent during the fourth quarter. Even smaller firms joined the trend, with Twelve Points Wealth Management boosting its investment by more than 50 percent in the first quarter. This collective action by sophisticated money managers presents a powerful message to the broader market.

Should investors sell immediately? Or is it worth buying Cleveland-Cliffs?

Looking Beyond Short-Term Challenges

The rationale behind this bullish activity becomes clearer upon examining the company’s underlying performance. While Cleveland-Cliffs reported a quarterly loss of $0.50 per share, it simultaneously delivered robust revenue that significantly surpassed analyst forecasts. The company’s revenue reached $4.93 billion, demonstrating fundamental operational strength.

These institutional investors appear to be focusing on the long-term prospects of the integrated steel and iron ore producer. Its strategic positioning within the domestic steel market and its solid revenue base suggest that current weakness may be viewed as a potential entry point. In a sector rife with macroeconomic uncertainty, this coordinated accumulation of shares points to professional confidence in the company’s resilience and future recovery.

The critical question for other investors now is whether these major market players have identified a compelling value proposition that the wider market has yet to recognize.

Ad

Cleveland-Cliffs Stock: Buy or Sell?! New Cleveland-Cliffs Analysis from September 21 delivers the answer:

The latest Cleveland-Cliffs figures speak for themselves: Urgent action needed for Cleveland-Cliffs investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 21.

Cleveland-Cliffs: Buy or sell? Read more here...

Tags: Cleveland-Cliffs
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Repligen Stock

Repligen Stock: Navigating Divergent Signals in Biotech Markets

Lam Research Stock

Lam Research Shares Surge as Analysts Revise Targets Upward

Avis Budget Stock

Avis Budget Faces Mounting Pressure as Major Investors Retreat

Recommended

Beyond Meat Stock

Beyond Meat Shares Surge in Meme-Stock Frenzy

11 months ago
iShares Global Clean Energy ETF Stock

The Hidden Concentration Risk in Clean Energy Investing

11 months ago
Solana Stock

Solana ETF Approval Looms as Regulatory Deadline Approaches

12 months ago
Macom Stock

M/A-COM Technology Shares Enter Expected Consolidation Phase

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Tokenization’s Green Light: Crypto Rallies Where Congress Stalled

5% Money Forces AI’s Believers to Show Their Math

Software Sends AI’s First Real Invoice as Yields Break 5%

Rheinmetall’s Order Book Pushes Past €80 Billion as New Shell Deal Lands

AI’s Warning Lights Flash as Crypto Steals the Spotlight

Oracle’s Backlog Defies the Bond Market While Crypto Bends

Trending

Morgan Stanley Stock
Newsletter

AI’s Next Bottleneck Isn’t Chips. It’s Cybersecurity.

by Stephanie Dugan
September 21, 2026
0

Dear readers, Yesterday we wrote about a market forced to separate cash machines from cash burners now...

Amazon Stock

Five Percent Yields Separate Cash Machines From Cash Burners

September 19, 2026
Coinbase Stock

Real Assets, Real Cash Flows: Wall Street’s Post-Hike Rotation

September 18, 2026
Coinbase Stock

Tokenization’s Green Light: Crypto Rallies Where Congress Stalled

September 17, 2026
Nvidia Stock

5% Money Forces AI’s Believers to Show Their Math

September 16, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • AI’s Next Bottleneck Isn’t Chips. It’s Cybersecurity.
  • Five Percent Yields Separate Cash Machines From Cash Burners
  • Real Assets, Real Cash Flows: Wall Street’s Post-Hike Rotation

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com